S-32
Application of nanomaterials for drug innovation and their risk
S32-1.
Effect of nanomaterials on the induction of cell death
S32-2.
Toxicity testing and assessment of nanomatrials
S32-3.
Present Status of Health Effect Studies on Nanomaterials
S32-4.
Present status of nanomaterial carcinogenic risk assessment
S32-5.
Percutaneous assessment of nanomaterial titanium dioxide in cosmetics
S32-6.
Efficacy and safety of γ-PGA nanoparticles as vaccine carrier